Getting latest data loading
Home / Morning Report / Morning Report – 5th February 2025

This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.

Morning Report - 5 February 2025

Yesterday’s UK 100 Leaders Price (p) % Chg
Entain PLC 734.8 5.7%
Marks And Spencer Group PLC 345.0 2.9%
Scottish Mortgage Investment Trust PLC 1,067.5 2.5%
International Consolidated Airlines Group S.A. 347.1 1.9%
Glencore PLC 348.6 1.9%

 

Yesterday’s UK 100 Laggards Price (p) % Chg
Vodafone Group PLC 65.1 -7.0%
Astrazeneca PLC 11,030.0 -2.2%
Ashtead Group PLC 5,042.0 -2.2%
Compass Group PLC 2,758.0 -1.7%
BAE Systems PLC 1,210.5 -1.7%

 

Major World Indices Price % Chg 1 YEAR
UK 100 INDEX 8,571 -0.2% 12.6%
DOW JONES INDUS. AVG 44,556 0.3% 16.1%
DAX INDEX 21,506 0.4% 27.2%
NIKKEI 225 38,831 0.1% 6.8%
S&P/ASX 200 INDEX 8,417 0.5% 10.4%
Commodities Units Price % Chg
WTI Crude Oil (Nymex) USD/bbl. 72.43 -0.37%
Brent Crude (ICE) USD/bbl. 75.82 -0.50%
Gold Spot USD/t oz. 2,858 0.6%
Copper (Comex) USd/lb. 437 0.5%

 

The UK 100 called to open -24 points at 8547

1 Day; 2 Years

Click graph to enlarge

Markets Overview:

The UK 100 called to open -24 points at 8547. The UK 100 looks set to open slightly lower this morning, having dropped 13 points yesterday.

In Asia this morning The Shanghai Composite was 0.7% lower after China markets reopened following the Lunar New Year holiday. The Hang Seng index has dropped 1.2%.

The Nasdaq and S&P moved higher on Tuesday due to a strong gain in Palantir, as Wall Street sought stable footing following the latest developments on the global trade front.  The tech-heavy index jumped 1.35% to 19,654.02, while the S&P 500 rose 0.72% to 6,037.88. The Dow Jones climbed 134.13 points, or 0.3%, to 44,556.04.

 

Company News & Broker Comments:

Company News:

GSK today increased its 2031 sales outlook to more than £40 billion, up from £38 billion amid stronger progress in its late-stage drugs pipeline.  Total 2024 sales in GSK’s annual results published today were £31.4 billion, a rise of 3%. This improves to 7% at constant exchange rates.  Core operating profit rose 11% without currency fluctuations, although the total fell 40% to £4 billion when including a one-off charge of £1.8 billion relating to the settlement of Zantac litigation.  GSK sees 2025 turnover growth at constant exchange rates of between 3% to 5%, with core operating profit growth of between 6% to 8%.  It declared a dividend of 16p for the fourth quarter and expects to increase the total for 2025 to 64p a share from 61p last year. A £2 billion share buyback programme is set to be implemented over the next 18 months.

 

 

Broker Comments:

No New Broker Comments

 

 

Reporting Today:

UK

 

DCC (DCC)

GSK (GSK)

Grainger (GRI)

JTC (JTC)

 

US

 

Novo Nordisk (NVO) PMO

Uber Technologies (UBER) PMO

The Walt Disney Co (DIS) PMO

ARM Holdings (ARM) AMC

Ford Motor Co (F) AMC

MicroStrategy (MSTR) AMC

Qualcomm Inc (QCOM) AMC

Reporting Tomorrow:

UK

 

Anglo American (AAL)

AstraZeneca (AZN)

Compass Group (CPG)

Watches of Switzerland Group (WOSG)

 

US

 

Bristol-Myers Squibb (BMY) PMO

Eli Lilly and Co (LLY) PMO

Philip Morris International (PM) PMO

Roblox (RBLX) PMO

Amazon.com (AMZN) AMC

Cloudflare (NET) AMC

Illumina (ILMN) AMC

Pinterest (PINS) AMC

Take-Two Interactive Software (TTWO) AMC

In Focus Today:

Chinese Caixin Services PMI

German HCOB Composite PMI

German HCOB Services PMI

EU HCOB Composite PMI

EU Producer Price Index

US ADP Employment Change

US S&P Global Composite PMI

US ISM Services PMI

US Fed’s Goolsbee speech

 

Tomorrow’s Ex-Dividends:

UK 100 companies going ex-dividend on 6th February 2025:

 

None

UK 250 companies going ex-dividend on 6th February 2025:

 

Paragon Banking Group

Bluefield Solar Income Fund

Aberforth Smaller Companies Trust

GCP Infrastructure Investments

Merchants Trust

Polar Capital Global Financials Trust

Henderson Smaller Cos Inv Tst

Impax Environmental Markets

For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.


Back to Top

This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.


Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
.